MedMen stock is currently up 2.09% and trading for $2.44 USD on the US exchange. The iconic, up-market US cannabis retailer (who’s stores emulate Apple’s in design) has performed poorly on the stock market in 2019. But despite this, Wall Street remains bullish on MedMen Enterprises (CSE:MMEN) (OTCQX:MMNFF). What gives?
MedMen Stock in 2019Giving it a consensus price target of $6.38 per share, as stated, Wall Street remains bullish on this cannabis play. Such a target represents a potential upswing of 161%—that’s pretty hefty.
This must be a head-scratcher for investors because MedMen ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.